OtherApr 10, 2026, 05:16 PM
Ekso Bionics Files Amended 2025 Annual Report (10-K/A)
AI Summary
Ekso Bionics Holdings, Inc. has filed an Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment provides updated administrative details regarding the company's regulatory status. The filing indicates that Ekso Bionics is a non-accelerated filer and a smaller reporting company, with the aggregate market value of its common stock held by non-affiliates recorded at $8,158,292 as of June 30, 2025.
Key Highlights
- Filed Form 10-K/A, Amendment No. 1, for the fiscal year ended December 31, 2025.
- Aggregate market value of non-affiliate common stock was $8,158,292 as of June 30, 2025.
- Company is classified as a non-accelerated filer and a smaller reporting company.
Price Impact
More from EKSO